Current treatment options of T cell-associated immunotherapy in multiple myeloma
Sign Up to like & getrecommendations! Published in 2017 at "Clinical and Experimental Medicine"
DOI: 10.1007/s10238-017-0450-9
Abstract: Multiple myeloma (MM) is a complex disease and is presently an incurable malignant plasma cell tumor. Although the introduction of proteasome inhibitor and the immunomodulators markedly improved the effect of myeloma therapy, most patients still… read more here.
Keywords: myeloma; options cell; cell associated; treatment options ... See more keywords